1.
Product Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for Study
1.2.3.
Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, and Trends
4.
Voice of Customer
5. Global Immunoassay
for Neurological Biomarkers Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Product (Instruments, Reagents, Services)
5.2.2.
By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple
Sclerosis, Others)
5.2.3.
By Application (In Vitro Diagnostics, Research)
5.2.4.
By Region (North America, Europe, Asia Pacific, South
America, Middle East & Africa)
5.2.5. By
Company (2023)
5.3.
Market Map
5.3.1. By Product
5.3.2. By Disease
5.3.3. By Application
5.3.4.
By Region
6.
North America Immunoassay for Neurological Biomarkers
Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Product
6.2.2. By Disease
6.2.3. By Application
6.2.4. By Country
6.3. North America:
Country Analysis
6.3.1. United States
Immunoassay for Neurological Biomarkers Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
6.3.1.2.2.
By Disease
6.3.1.2.3.
By Application
6.3.2. Canada Immunoassay
for Neurological Biomarkers Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product
6.3.2.2.2.
By Disease
6.3.2.2.3.
By Application
6.3.3. Mexico Immunoassay
for Neurological Biomarkers Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product
6.3.3.2.2.
By Disease
6.3.3.2.3.
By Application
7.
Europe Immunoassay for Neurological Biomarkers Market
Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Product
7.2.2. By Disease
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country
Analysis
7.3.1. Germany Immunoassay
for Neurological Biomarkers Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Disease
7.3.1.2.3.
By Application
7.3.2. France Immunoassay
for Neurological Biomarkers Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Disease
7.3.2.2.3.
By Application
7.3.3. United Kingdom
Immunoassay for Neurological Biomarkers Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Disease
7.3.3.2.3.
By Application
7.3.4. Italy Immunoassay
for Neurological Biomarkers Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Disease
7.3.4.2.3.
By Application
7.3.5. Spain Immunoassay
for Neurological Biomarkers Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Disease
7.3.5.2.3.
By Application
8.
Asia Pacific Immunoassay for Neurological Biomarkers
Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Product
8.2.2. By Disease
8.2.3. By Application
8.2.4. By Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China Immunoassay
for Neurological Biomarkers Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Disease
8.3.1.2.3.
By Application
8.3.2. Japan Immunoassay
for Neurological Biomarkers Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Disease
8.3.2.2.3.
By Application
8.3.3. India Immunoassay
for Neurological Biomarkers Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Disease
8.3.3.2.3.
By Application
8.3.4. South Korea
Immunoassay for Neurological Biomarkers Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Disease
8.3.4.2.3.
By Application
8.3.5. Australia
Immunoassay for Neurological Biomarkers Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Disease
8.3.5.2.3.
By Application
9.
South America Immunoassay for Neurological Biomarkers
Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Product
9.2.2. By Disease
9.2.3. By Application
9.2.4. By Country
9.3. South America:
Country Analysis
9.3.1. Brazil Immunoassay
for Neurological Biomarkers Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Disease
9.3.1.2.3.
By Application
9.3.2. Argentina
Immunoassay for Neurological Biomarkers Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Disease
9.3.2.2.3.
By Application
9.3.3. Colombia Immunoassay
for Neurological Biomarkers Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Disease
9.3.3.2.3.
By Application
10.
Middle East and Africa Immunoassay for Neurological
Biomarkers Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product
10.2.2. By Disease
10.2.3. By Application
10.2.4. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Immunoassay for
Neurological Biomarkers Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Disease
10.3.1.2.3.
By Application
10.3.2. Saudi Arabia
Immunoassay for Neurological Biomarkers Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Disease
10.3.2.2.3.
By Application
10.3.3. UAE Immunoassay for Neurological Biomarkers Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Disease
10.3.3.2.3.
By Application
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Merger & Acquisition
12.2.
Product Development
12.3.
Recent Developments
13.
Porter’s
analysis
14.
PESTEL
analysis
15.
Competitive Landscape
15.1. QIAGEN NV
15.1.1. Business Overview
15.1.2.
Company Snapshot
15.1.3.
Products & Services
15.1.4.
Financials (As Reported)
15.1.5.
Recent Developments
15.2.
Abbott Laboratories
Inc.
15.3.
Merck & Co.,
Inc.
15.4.
Johnson &
Johnson Services, Inc.
15.5.
Thermo Fisher
Scientific, Inc.
15.6.
Bio-Rad
Laboratories, Inc.
15.7.
Sysmex Corporation
15.8. F. Hoffmann
La-Roche Ltd.
15.9. Nimble Therapeutics Inc.
16. Strategic Recommendations17. About Us & Disclaimer